Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Levobupivacaine Continuous Wound Infiltration and Optimal Standard Analgesia Versus Optimal Standard Analgesia Alone After Cesarean Section.

NCT01751256 is registered in ClinicalTrials.gov with Poissy-Saint Germain Hospital as lead sponsor.

NCT NCT01751256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01751256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Levobupivacaine Continuous Wound Infiltration and Optimal Standard Analgesia Versus Optimal Standard Analgesia Alone After Cesarean Section.
Lead sponsor
Poissy-Saint Germain Hospital
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2010
Completion date
December 31, 2011
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, local, breast feeding, postoperative pain